For patients with advanced ovarian cancer, a simple test can identify who is likely to benefit from targeted therapy—yet many in Canada still can't access it. A new study, funded through a MOHCCN Patient Voices in Research Award, explores why. Learn more: tinyurl.com/3r6r825k

Data helps #precisionmedicine target therapies for success. Learn more in our first 'Data in Action' story #AIAppreciationDay #DataAnalytics #braincancer

2025 MOHCCN Clinician Scientist awardee, Dr. Teresa Purzner is developing new tools to better understand and tackle recurrence. www.marathonofhopecancercentres.ca/our-research... @queensuresearch.bsky.social

Glioblastoma is one of the deadliest cancers, with a median survival rate of less than 15 months. Even after intensive treatment, the disease almost always returns. We're highlighting some of the Terry Fox-funded researchers working to change what’s possible for people facing glioblastoma.

Dr. Rodney J. Ouellette has made invaluable contributions to MOHCCN since the Network’s inception. Congratulations, Dr. Ouellette, on your appointment to the Canadian Senate.

Terry Fox Research Institute (TFRI)@terryfoxresearch.bsky.social · 4w ago

TFRI proudly congratulates Dr. Rodney J. Ouellette on his appointment to the Canadian Senate. A dedicated researcher, clinician, and longtime Terry Foxer, Dr. Ouellette has helped shape TFRI, MOHCCN, and DHDP through his leadership and commitment to advancing cancer research in Canada.

Join us in celebrating Peter Mothe and Erin Jackson as they step into new communications leadership positions at TFRI. 👏👏👏

Terry Fox Research Institute (TFRI)@terryfoxresearch.bsky.social · last mo.

The Terry Fox Research Institute is pleased to announce the appointments of Peter Mothe as Director of Communications and Erin Jackson into the new position of Communications Manager. www.tfri.ca/updates/news...

TFRI and @marathonofhope.bsky.social are proud to congratulate Dr. Morag Park on her appointment as President and Scientific Director of the Gairdner Foundation. Learn more about Dr. Park's contributions to the TFRI community and Canadian cancer research: www.tfri.ca/updates/news...

June is Cancer Survivors Month: What do cancer survivors wish researchers knew? Kirsten Efremov, three-time cancer survivor and MOHCCN Patient Working Group member, shared with us why meaningful engagement goes beyond asking for patient input—it means listening and acting on what patients tell you.

Cancer Immunotherapy Month: How gut bacteria influence immunotherapy outcomes Clinician Scientist Awardee Dr. Bertrand Routy shows microbiome differences may explain varied lung cancer immunotherapy response, enabling better prediction and microbiome-guided care. Learn more: tinyurl.com/muddje4n

🍁📈Final Phase I Dashboard Update: Target exceeded!🍁📈 With MOHCCN Phase I now closed, we’re proud to share that we surpassed our original goal of 15k cases! Together, we've built a resource that will benefit cancer research and patients for years to come. Thank you to everyone who contributed!

"Survivor" is a powerful word, but it doesn't tell the whole story. Kirsten Efremov, 3-time cancer survivor and MOHCCN Patient Working Group member, sat down with us to share what she wishes people understood beyond the label "cancer survivor." Visit the MOHCCN Patient Hub: tinyurl.com/wkmy7fma

June is Cancer Immunotherapy Month. Immunotherapy is one of the most promising areas of oncology research today and could transform how cancer is treated. TFRI invests in world-class immunotherapy research to help advance life-changing discoveries. Learn more: www.tfri.ca/about-cancer...

🧫 What if doctors could test cancer drugs on a patient's tumour before choosing a treatment? 🧫 Read the full Q&A with Dr. Robert Grant to learn how organoid-based drug testing could help improve treatment options for pancreatic cancer patients: www.marathonofhopecancercentres.ca/impact/news-...

🔬 Tracking how glioblastoma evolves to outsmart treatment 🔬 With a MOHCCN Clinician-Scientist Award, Dr. Ana Nikolic found that DNA regulatory regions change predictably as tumours recur, revealing how GBM resists therapy. Read the full Q&A to learn more about this project: tinyurl.com/ms8tzemt

Research informs care—and care informs research Over the last 5 years, MOHCCN-funded projects have brought precision oncology and new hope to patients nationwide. The lessons learned along the way are informing care for the future, creating a virtuous cycle of growth. @marathonofhope.bsky.social

May is Cancer Research Month Terry Fox believed research could save lives. That’s why TFRI provides funding to world-class cancer research and initiatives like the Marathon of Hope Cancer Centres Network and the Digital Health & Discovery Platform.

🦠Could the microbiome help determine how patients respond to immunotherapy?🦠 MOHCCN Clinician-Scientist awardee Dr. Bertrand Routy has identified a lung bacterium that may promote tumour growth and impact treatment response. Learn more: tinyurl.com/muddje4n

Hear from investigator, Parsa Bagherzadeh on how AI can automate the reporting process for surgical pathology results, correctly identifying features for faster decisions on treatment options. vimeo.com/1148674915?f...

One project funded by @marathonofhope.bsky.social used #ML to analyze imaging, clinical and genomic data to accelerate #precisiononcology for melanoma. www.marathonofhopecancercentres.ca/our-research... @McGill.ca @rimuhc.bsky.social @healthsciences.mcgill.ca

🛡️ MOHCCN researchers may have uncovered why some breast cancers keep immune cells out 🛡️ Immunotherapy has reshaped cancer care, but some tumours block immune cells. MOHCCN researchers in Nova Scotia found THSD4 helps stop T cells entering HR+ breast cancer tumours. Learn more: tinyurl.com/d48m8byz

💡Investigating why some cases of basal cell carcinoma become aggressive: A Q&A with Dr. Philippe Lefrançois💡 Funded through the Network’s Clinician-Scientist Award, Dr. Lefrançois and his team uncovered a novel pathway linked to Canada’s most common cancer. Read more: tinyurl.com/mwvfszaw

📺 Missed the last event in our Patient Voices in Research seminar series? The recording is now available, along with all four events in the series. 📺 Watch all the events and discover more seminars showcasing life-changing cancer research from experts across Canada: tinyurl.com/2mk9zb4d

MOHCCN Seminar Series

The Marathon of Hope Cancer Centres Network is a bold vision led by The Terry Fox Research Institute and The Terry Fox Foundation with support from dozens of research and funding partners across Canad...

tinyurl.com

🩺 Could immunotherapy work for more pancreatic cancer patients than previously believed? 🩺 A new study by Network researchers at Dalhousie University suggests that immunotherapy could be beneficial for at least a subset of people with pancreatic cancer. Learn more: tinyurl.com/43aes97p

Curious how precision oncology drugs are approved for reimbursement in Canada? How we can help patients learn about their disease? How fitness plans can improve outcomes for rare blood cancers? Join the last Patient Voices in Research Seminar. Register now 👉 tinyurl.com/raxekckd More info 👇

Marathon of Hope Cancer Centres Network@marathonofhope.bsky.social · 3mo ago

📣 Don't miss the last event in our Patient Voices in Research Initiative Seminar Series 📣 🩺 Patient Voices in Research Initiative (pt. 4) 📅 Thursday, May 14, 2026 ⌚ 12 pm PT / 1 pm MT / 2 pm CT / 3 pm ET / 4 pm AT / 4:30pm NT 📝 Register now: events.teams.microsoft.com/event/cdc76d...

📣 Don't miss the last event in our Patient Voices in Research Initiative Seminar Series 📣 🩺 Patient Voices in Research Initiative (pt. 4) 📅 Thursday, May 14, 2026 ⌚ 12 pm PT / 1 pm MT / 2 pm CT / 3 pm ET / 4 pm AT / 4:30pm NT 📝 Register now: events.teams.microsoft.com/event/cdc76d...

🍁 What it really takes to build a national cancer research resource 🍁 5 years ago, we set out to build Canada’s largest and most comprehensive cancer resource. While we achieved our goal (and even exceeded it!), getting there wasn't straightforward! Here's what we learned: tinyurl.com/5n6dmykr

📣 This Wednesday and Thursday! 📣 Our Patient Voices in Research Initiative Seminar Series continues this week. Discover innovative cancer research and join meaningful conversations with patients, survivors, and caregivers. 📝Register now: www.marathonofhopecancercentres.ca/researcher-h...

🍁Vous avez manqué le Forum pan-canadien des patients de ce dimanche ?🍁 L'enregistrement complet est maintenant disponible ! Vous pouvez également accéder à des ressources élaborées par notre Groupe de travail des patients, et en savoir plus sur le MOHCCN et ses initiatives. tinyurl.com/yt958ekh

Forum pan-canadien des patients 

The Marathon of Hope Cancer Centres Network is the realization of a long-standing vision of the Terry Fox Research Institute and is funded with the support of the Terry Fox Foundation and the generosi...

tinyurl.com

📆 Mark your calendars-We’ve got a full line-up of Patient Working Group-led events happening this May! 📅 All events are free, virtual, and open to anyone interested in learning more about precision oncology. Learn more below 🔽🧵 Stay tuned more MOHCCN events to be announced soon!

There’s one question that almost every patient that walks into Dr. Amy Trottier's blood cancer clinic in Halifax asks: why me? As she explains in our latest Network Voices piece, the answer is increasingly found in an unexpected place: their family tree. Read now ▶️: tinyurl.com/5fu6p6f3